(R,S)-Rolipram, Selective PDE4 inhibitor
Be the first to review this product! Submit a review
|
(7 Publications)
MW 275.34 Da, Purity >99%. Selective cAMP-specific phosphodiesterase PDE4 inhibitor (IC50 values are 1.1 and 0.17 μM for inhibition of mouse PDE4A1 and PDE4B, respectively).
View Alternative Names
5''-cyclic phosphodiesterase 4A, DPDE2, PDE4, PDE46, PDE4A11, PDE4A_HUMAN, Phosphodiesterase 4A, Phosphodiesterase 4A, cAMP-specific (dunce, Phosphodiesterase E2 dunce homolog, Drosophila, cAMP specific phosphodiesterase, cAMP-specific 3'', cAMP-specific 3',5'-cyclic phosphodiesterase 4A, dunce like phosphodiesterase E2, phosphodiesterase 4A cAMP specific, phosphodiesterase E2 dunce homolog, phosphodiesterase isozyme 4, phosphodiesterase type 4A11
- Chemical Structure
Lab
Chemical Structure - (R,S)-Rolipram, Selective PDE4 inhibitor (AB120029)
2D chemical structure image of ab120029, (R,S)-Rolipram, Selective PDE4 inhibitor
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PDE4A plays an important role in regulating intracellular levels of cyclic adenosine monophosphate (cAMP) a critical component in signaling pathways that affect numerous cellular processes. By controlling cAMP concentrations PDE4A regulates inflammatory responses and airway smooth muscle contraction which is important for respiratory functions. PDE4A does not function within a complex but operates as a homodimer when exerting its effects on signaling cascades.
Pathways
PDE4A's role is significant in the cAMP-dependent signaling pathway. This pathway influences processes like inflammation and smooth muscle relaxation. PDE4A interacts with various proteins such as PKA (protein kinase A) which is activated by cAMP and mediates several downstream effects. By influencing the cAMP pathway PDE4A affects bodily responses including immune and respiratory systems.
Publications (7)
Recent publications for all applications. Explore the full list and refine your search
STAR protocols 3:101544 PubMed35842863
2022
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 41:e109457 PubMed35603814
2022
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 12:3589 PubMed35246566
2022
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 9: PubMed34440254
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cells 10: PubMed34065927
2021
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 39:e104929 PubMed32954504
2020
Applications
Unspecified application
Species
Unspecified reactive species
Science (New York, N.Y.) 327:547-52 PubMed20110498
2010
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com